OssDsign entered commercial partnerships covering distribution of its products for cranial repair and facial bone reconstruction in Italy, Spain, Switzerland, Austria and The Netherlands.
OSSDSIGN® Cranial and OSSDSIGN® Facial are presently marketed in Germany, the U.K. and the Nordic region, as well as select non-EU markets including Singapore and Israel.
The company is preparing for U.S. product launch in 1Q17, and is also pursuing regulatory and commercial activities in Japan.
OssDsign (formerly Oss-Q) has developed a bioceramic material with a chemical composition similar to bone, with a focus on cranial surgery and future applications in fracture healing.
Sources: OssDsign AB; ORTHOWORLD Inc.